[go: up one dir, main page]

AU1926699A - Cathepsin dc proteins, dna encoding the proteins, and their use in human cancer prognosis - Google Patents

Cathepsin dc proteins, dna encoding the proteins, and their use in human cancer prognosis

Info

Publication number
AU1926699A
AU1926699A AU19266/99A AU1926699A AU1926699A AU 1926699 A AU1926699 A AU 1926699A AU 19266/99 A AU19266/99 A AU 19266/99A AU 1926699 A AU1926699 A AU 1926699A AU 1926699 A AU1926699 A AU 1926699A
Authority
AU
Australia
Prior art keywords
proteins
cathepsin
dna encoding
human cancer
cancer prognosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU19266/99A
Other languages
English (en)
Inventor
Dirk Michael Anderson
Terry Y. Nakagawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunex Corp
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp filed Critical Immunex Corp
Publication of AU1926699A publication Critical patent/AU1926699A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6472—Cysteine endopeptidases (3.4.22)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU19266/99A 1997-12-18 1998-12-18 Cathepsin dc proteins, dna encoding the proteins, and their use in human cancer prognosis Abandoned AU1926699A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6940997P 1997-12-18 1997-12-18
US60069409 1997-12-18
PCT/US1998/026920 WO1999031256A2 (fr) 1997-12-18 1998-12-18 Proteines cathepsine dc, adn codant pour ces proteines et utilisation de ces proteines dans l'etablissement de pronostics pour les cancers chez l'homme

Publications (1)

Publication Number Publication Date
AU1926699A true AU1926699A (en) 1999-07-05

Family

ID=22088795

Family Applications (1)

Application Number Title Priority Date Filing Date
AU19266/99A Abandoned AU1926699A (en) 1997-12-18 1998-12-18 Cathepsin dc proteins, dna encoding the proteins, and their use in human cancer prognosis

Country Status (2)

Country Link
AU (1) AU1926699A (fr)
WO (1) WO1999031256A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60224002T2 (de) * 2002-02-14 2008-11-06 Biofrontera Pharmaceuticals Ag Kathepsin Y Inhibitoren für die Entwicklung von Medikamenten zur Schmerzbehandlung
US6974672B2 (en) 2002-03-19 2005-12-13 Amgen Inc. Gene amplification in cancer
AU2003210347A1 (en) * 2003-02-25 2004-09-17 Biofrontera Pharmaceuticals Gmbh Cathepsin y for the treatment of pain
JP2007516725A (ja) * 2003-12-30 2007-06-28 アベンティス・ファーマスーティカルズ・インコーポレイテツド 関節リウマチ及び他の自己免疫疾患の治療のためのカテプシンｚ阻害剤の使用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996039194A1 (fr) * 1995-06-06 1996-12-12 Athena Neurosciences, Inc. Nouvelle cathepsine et procedes et compositions d'inhibition de cathepsine

Also Published As

Publication number Publication date
WO1999031256A2 (fr) 1999-06-24
WO1999031256A3 (fr) 1999-11-04

Similar Documents

Publication Publication Date Title
AU9312198A (en) Genes amplified in tumours, antibodies against the proteins encoded thereby, andtheir use in diagnosis and treatment of cancer
HUP0104825A3 (en) Genes and proteins, and their use
AU2068599A (en) Polypeptides, dna coding therefor, formulations thereof, and their use in inhibiting factor xii activation
AU5475199A (en) Human chordin-related proteins and polynucleotides encoding them
AU3670395A (en) Hippocampus-associated proteins, dna sequences coding therefor and uses thereof
AU4328399A (en) Nucleic acid-cobalamin complexes and their use in gene therapy
AU1926699A (en) Cathepsin dc proteins, dna encoding the proteins, and their use in human cancer prognosis
IL131247A0 (en) Cash protein its preparation and use
HUP0201022A3 (en) Outer surface proteins, their genes, and their use
AU8772598A (en) Dna encoding the human synapsin iii gene and uses thereof
AU2001245367A1 (en) Human transporter genes and proteins encoded thereby
AU2001241446A1 (en) Human transporter proteins and polynucleotides encoding the same
AU6550598A (en) Antithrombin protein and dna sequences
GB9824357D0 (en) Protein and DNA coding therefor
AU2076701A (en) Novel human transporter protein and polynucleotides encoding the same
AU1690200A (en) Novel protein and dna thereof
AU2001275337A1 (en) Novel human transporter proteins and polynucleotides encoding the same
GB9824569D0 (en) Virulence gene and protein,and their use
AU2001274923A1 (en) Novel human thrombospondin-like proteins and polynucleotides encoding the same
AU8953201A (en) A novel polypeptide, a human dna methylation protein and the polynucleotide encoding the polypeptide
AU3010199A (en) Human leupaxin polypeptide and dna encoding it, their uses
AU5447999A (en) Novel protein and dna thereof
AU2001247283A1 (en) Human transporter proteins and polynucleotides encoding the same
AU2001241673A1 (en) Novel human regulatory protein and polynucleotides encoding the same
AU2003236302A1 (en) Virulence genes and proteins, and their use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase